litlas
ログインアカウント作成

Paul Nathan

1978–2025 年に発表

104
論文数
26,658
被引用数
68
h 指数
102
i10 指数

被引用数

Paul Nathan の年別被引用数1956 年: 被引用 1 件1971 年: 被引用 1 件1981 年: 被引用 1 件1982 年: 被引用 3 件1983 年: 被引用 1 件1984 年: 被引用 3 件1985 年: 被引用 4 件1986 年: 被引用 2 件1987 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 3 件1994 年: 被引用 2 件1995 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 3 件2001 年: 被引用 2 件2006 年: 被引用 2 件2007 年: 被引用 4 件2008 年: 被引用 4 件2009 年: 被引用 4 件2010 年: 被引用 18 件2011 年: 被引用 32 件2012 年: 被引用 54 件2013 年: 被引用 197 件2014 年: 被引用 263 件2015 年: 被引用 359 件2016 年: 被引用 345 件2017 年: 被引用 422 件2018 年: 被引用 380 件2019 年: 被引用 1,096 件2020 年: 被引用 1,140 件2021 年: 被引用 1,078 件2022 年: 被引用 927 件2023 年: 被引用 794 件2024 年: 被引用 1,312 件2025 年: 被引用 645 件2026 年: 被引用 26 件1957〜1970 年は被引用が無いため表示していません1972〜1980 年は被引用が無いため表示していません1990〜1993 年は被引用が無いため表示していません2002〜2005 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,649 件、この内訳の 23.1%中国: 引用元論文 945 件、この内訳の 8.2%イタリア: 引用元論文 804 件、この内訳の 7%イギリス: 引用元論文 795 件、この内訳の 6.9%ドイツ: 引用元論文 676 件、この内訳の 5.9%フランス: 引用元論文 656 件、この内訳の 5.7%オーストラリア: 引用元論文 488 件、この内訳の 4.3%オランダ: 引用元論文 445 件、この内訳の 3.9%スペイン: 引用元論文 395 件、この内訳の 3.4%カナダ: 引用元論文 366 件、この内訳の 3.2%スイス: 引用元論文 316 件、この内訳の 2.8%日本: 引用元論文 270 件、この内訳の 2.4%
0%23.1%その他 23.2%

機関

分野

  • Medicine60.3%
  • Biochemistry, Genetics and Molecular Biology31.6%
  • Immunology and Microbiology3.6%
  • Computer Science0.9%
  • Engineering0.7%
  • Chemistry0.7%
  • その他2.2%

トピック

  • Cancer Immunotherapy and Biomarkers9.8%
  • Melanoma and MAPK Pathways8.8%
  • Cutaneous Melanoma Detection and Management5.6%
  • Immunotherapy and Immune Responses4.5%
  • CAR-T cell therapy research4.4%
  • Renal cell carcinoma treatment4.1%
  • その他62.8%

共著者

全論文

検索で開く
  1. Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

    著者: Paul Nathan, Jessica C. Hassel, Piotr Rutkowski, Jean‐François Baurain, Marcus O. Butler, Max Schlaak, Ryan J. Sullivan, Sebastian Ochsenreither, Reinhard Dummer, John M. Kirkwood, Anthony M. Joshua, Joseph J. Sacco, Alexander N. Shoushtari, Marlana Orloff, Josep M. Piulats, Mohammed Milhem, April K.S. Salama, Brendan D. Curti, Lev Demidov, Lauris Gastaud, Cornelia Mauch, Melinda Yushak, Richard D. Carvajal, Omid Hamid, Shaad E. Abdullah, Chris Holland, Howard Goodall, Sophie Piperno‐Neumann - New England Journal of Medicine 2021 被引用: 878

  2. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma

    著者: Karla A. Lee, Andrew Maltez Thomas, Laura A. Bolte, Johannes R. Björk, Laura Kist de Ruijter, Federica Armanini, Francesco Asnicar, Aitor Blanco‐Míguez, Ruth Board, Neus Calbet‐Llopart, Lisa Derosa, Nathalie Dhomen, Kelly Brooks, Mark Harland, Mark Harries, Emily R. Leeming, Paul Lorigan, Paolo Manghi, Richard Marais, Julia Newton‐Bishop, Luigi Nezi, Federica Pinto, Míriam Potrony, Susana Puig, Patricio Serra-Bellver, Heather M. Shaw, Sabrina Tamburini, Sara Valpione, Amrita Vijay, Levi Waldron, Laurence Zitvogel, Moreno Zolfo, Elisabeth G.E. de Vries, Paul Nathan, Rudolf S.N. Fehrmann, Véronique Bataille, Geke A.P. Hospers, Tim D. Spector, Rinse K. Weersma, Nicola Segata - Nature Medicine 2022 被引用: 429

  3. Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma

    著者: Caroline Robert, Jean‐Jacques Grob, Daniil Stroyakovskiy, Bogusława Karaszewska, Axel Hauschild, E. Levchenko, Vanna Chiarion‐Sileni, Jacob Schachter, Claus Garbe, Igor Bondarenko, Helen Gogas, Mario Mandalà, John B.A.G. Haanen, Célèste Lebbé, Andrzej Maćkiewicz, Piotr Rutkowski, Paul Nathan, Antoni Ribas, Michael A. Davies, Keith T. Flaherty, Paul Burgess, Monique Tan, Eduard Gasal, Maurizio Voi, Dirk Schadendorf, Georgina V. Long - New England Journal of Medicine 2019 被引用: 1,376

  4. Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

    著者: Caroline Robert, Bogusława Karaszewska, Jacob Schachter, Piotr Rutkowski, Andrzej Maćkiewicz, D. Stroiakovski, M. Lichinitser, Reinhard Dummer, Florent Grange, Laurent Mortier, Vanna Chiarion‐Sileni, Kamil Drucis, Ivana Krajsová, Axel Hauschild, Paul Lorigan, Pascal Wolter, Georgina V. Long, Keith T. Flaherty, Paul Nathan, Antoni Ribas, Anne-Marie Martin, Peng Sun, Wendy Crist, Jeff Legos, Stephen D. Rubin, Shonda M Little, Dirk Schadendorf - New England Journal of Medicine 2014 被引用: 2,655

  5. Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

    著者: Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas, E. Levchenko, Filippo de Braud, James Larkin, Claus Garbe, Thomas Jouary, Axel Hauschild, Jean‐Jacques Grob, Vanna Chiarion‐Sileni, Célèste Lebbé, Mario Mandalà, Michael Millward, Ana Arance, Igor Bondarenko, John B.A.G. Haanen, Johan Hansson, Jochen Utikal, Virginia Ferraresi, Н. В. Коваленко, Peter Mohr, Volodymyr Probachai, Dirk Schadendorf, Paul Nathan, Caroline Robert, Antoni Ribas, Douglas J. DeMarini, Jhangir G Irani, Michelle Casey, Danièle Ouellet, Anne‐Marie Martin, Ngocdiep T. Le, Kiran Patel, Keith T. Flaherty - New England Journal of Medicine 2014 被引用: 1,871

  6. Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

    著者: Jessica C. Hassel, Sophie Piperno‐Neumann, Piotr Rutkowski, Jean‐François Baurain, Max Schlaak, Marcus O. Butler, Ryan J. Sullivan, Reinhard Dummer, John M. Kirkwood, Marlana Orloff, Joseph J. Sacco, Sebastian Ochsenreither, Anthony M. Joshua, Lauris Gastaud, Brendan D. Curti, Josep M. Piulats, April K.S. Salama, Alexander N. Shoushtari, Lev Demidov, Mohammed Milhem, Bartosz Chmielowski, Kevin B. Kim, Richard D. Carvajal, Omid Hamid, Laura Collins, Koustubh Ranade, Chris Holland, Constance R. Pfeiffer, Paul Nathan - New England Journal of Medicine 2023 被引用: 261

  7. Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

    著者: Keith T. Flaherty, Caroline Robert, Peter Hersey, Paul Nathan, Claus Garbe, Mohammed Milhem, Lev Demidov, Jessica C. Hassel, Piotr Rutkowski, Peter Mohr, Reinhard Dummer, Uwe Trefzer, James Larkin, Jochen Utikal, Brigitte Dréno, Marta Nyakas, Mark R. Middleton, Jürgen C. Becker, Michelle Casey, Laurie Sherman, Frank Wu, Danièle Ouellet, Anne‐Marie Martin, Kiran Klaus Patel, Dirk Schadendorf - New England Journal of Medicine 2012 被引用: 2,141

  8. Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

    著者: Robert J. Motzer, Brian I. Rini, David F. McDermott, Osvaldo Arén Frontera, Hans J. Hammers, Michael A. Carducci, Pamela Salman, Bernard Escudier, Benoit Beuselinck, Asim Amin, Camillo Porta, Saby George, Victoria Neiman, Sergio Bracarda, Scott S. Tykodi, Philippe Barthélémy, Raya Leibowitz‐Amit, Elizabeth R. Plimack, Sjoukje F. Oosting, Bruce G. Redman, Bohuslav Melichar, Thomas Powles, Paul Nathan, Stéphane Oudard, David Pook, Toni K. Choueiri, Frede Donskov, Marc‐Oliver Grimm, Howard Gurney, Daniel Y.C. Heng, Christian Kollmannsberger, Michael R. Harrison, Yoshihiko Tomita, Ignacio Durán, Viktor Grünwald, M. Brent McHenry, Sabeen Mekan, Nizar M. Tannir - The Lancet Oncology 2019 被引用: 780

  9. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

    著者: Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas, E. Levchenko, Filippo de Braud, James Larkin, Claus Garbe, Thomas Jouary, Axel Hauschild, Jean‐Jacques Grob, Vanna Chiarion‐Sileni, Célèste Lebbé, Mario Mandalà, Michael Millward, Ana Arance, Igor Bondarenko, John B.A.G. Haanen, Johan Hansson, Jochen Utikal, Virginia Ferraresi, Н. В. Коваленко, Peter Mohr, Volodymr Probachai, Dirk Schadendorf, Paul Nathan, Caroline Robert, Antoni Ribas, Douglas J. DeMarini, Jhangir G Irani, S. Swann, Jeffrey J. Legos, Fan Jin, Bijoyesh Mookerjee, Keith T. Flaherty - The Lancet 2015 被引用: 1,386

  10. Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial

    著者: Richard D. Carvajal, Marcus O. Butler, Alexander N. Shoushtari, Jessica C. Hassel, Alexandra P. Ikeguchi, Leonel F. Hernandez‐Aya, Paul Nathan, Omid Hamid, Josep M. Piulats, Matthew J. Rioth, Douglas B. Johnson, Jason J. Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Howard Goodall, Koustubh Ranade, Chris Holland, Shaad E. Abdullah, Joseph J. Sacco, Takami Sato - Nature Medicine 2022 被引用: 152

  11. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022

    著者: Claus Garbe, Teresa Amaral, Ketty Peris, Axel Hauschild, Petr Arenberger, Nicole Basset‐Séguin, Lars Bastholt, Véronique Bataille, V. del Mármol, Brigitte Dréno, Maria Concetta Fargnoli, Ana‐Maria Forsea, Jean-Jacques Grob, Christoph Höller, Roland Kaufmann, Nicole W.J. Kelleners-Smeets, Aimilios Lallas, Célèste Lebbé, Bohdan Lytvynenko, Josep Malvehy, D. Moreno‐Ramírez, Paul Nathan, Giovanni Pellacani, Philippe Saïag, Alexander J. Stratigos, Alexander C. J. van Akkooi, Ricardo Vieira, Iris Zalaudek, Paul Lorigan - European Journal of Cancer 2022 被引用: 321

  12. Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238

    著者: James Larkin, Michele Del Vecchio, Mario Mandalà, Helen Gogas, Ana Arance, Stéphane Dalle, Charles Lance Cowey, Michael Schenker, Jean‐Jacques Grob, Vanna Chiarion‐Sileni, Iván Márquez‐Rodas, Marcus O. Butler, Anna Maria Di Giacomo, Mark R. Middleton, Jose Lutzky, Luis de la Cruz‐Merino, Petr Arenberger, Victoria Atkinson, Andrew G. Hill, Leslie A. Fecher, Michael Millward, Paul Nathan, Nikhil I. Khushalani, Paola Queirolo, Corey Ritchings, Maurice Lobo, Margarita Askelson, Hao Tang, Sonia Dolfi, Paolo A. Ascierto, Jeffrey S. Weber - Clinical Cancer Research 2023 被引用: 180

  13. Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma

    著者: Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas, Karla A. Lee, Niccolò Rossi, Thijs T. Wind, Lotte M. Smit, Federica Armanini, Francesco Asnicar, Aitor Blanco‐Míguez, Ruth Board, Neus Calbet‐Llopart, Lisa Derosa, Nathalie Dhomen, Kelly Brooks, Mark Harland, Mark Harries, Paul Lorigan, Paolo Manghi, Richard Marais, Julia Newton‐Bishop, Luigi Nezi, Federica Pinto, Míriam Potrony, Susana Puig, Patricio Serra-Bellver, Heather M. Shaw, Sabrina Tamburini, Sara Valpione, Levi Waldron, Laurence Zitvogel, Moreno Zolfo, Elisabeth G.E. de Vries, Paul Nathan, Rudolf S.N. Fehrmann, Tim D. Spector, Véronique Bataille, Nicola Segata, Geke A.P. Hospers, Rinse K. Weersma - Nature Medicine 2024 被引用: 124

  14. Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

    著者: Robert J. Motzer, Thomas E. Hutson, David Cella, James A. Reeves, Robert D. Hawkins, Jun Guo, Paul Nathan, Michael Staehler, Paul de Souza, Jaime R. Merchan, Ekaterini Boleti, Kate Fife, Jie Jin, Robert J. Jones, Hirotsugu Uemura, Ugo De Giorgi, Ulrika Harmenberg, Jinwan Wang, Cora N. Sternberg, Keith C. Deen, Lauren McCann, Michelle D. Hackshaw, Rocco J. Crescenzo, Lini Pandite, Toni K. Choueiri - New England Journal of Medicine 2013 被引用: 1,918

  15. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022

    著者: Claus Garbe, Teresa Amaral, Ketty Peris, Axel Hauschild, Petr Arenberger, Nicole Basset‐Séguin, Lars Bastholt, Véronique Bataille, V. del Mármol, Brigitte Dréno, Maria Concetta Fargnoli, Ana‐Maria Forsea, Jean‐Jacques Grob, Christoph Höeller, Roland Kaufmann, Nicole W.J. Kelleners-Smeets, Aimilios Lallas, Célèste Lebbé, Bodhan Lytvynenko, Josep Malvehy, D. Moreno‐Ramírez, Paul Nathan, Giovanni Pellacani, Philippe Saïag, Alexander J. Stratigos, Alexander C. J. van Akkooi, Ricardo Vieira, Iris Zalaudek, Paul Lorigan - European Journal of Cancer 2022 被引用: 287

  16. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023

    著者: Ketty Peris, Maria Concetta Fargnoli, Roland Kaufmann, Petr Arenberger, Lars Bastholt, N. Basset Seguin, Véronique Bataille, Liève Brochez, V. del Mármol, Reinhard Dummer, Ana-Marie Forsea, Caroline Gaudy‐Marqueste, Catherine Harwood, Axel Hauschild, Christoph Höller, Lidija Kandolf, Nicole W.J. Kellerners-Smeets, Aimilios Lallas, Ulrike Leiter, Josep Malvehy, Branka Marinović, Željko Mijušković, D. Moreno‐Ramírez, Eduardo Nagore, Paul Nathan, Alexander Stratigos, Eggert Stockfleth, Luca Tagliaferri, Myrto Trakatelli, Ricardo Vieira, Iris Zalaudek, Claus Garbe - European Journal of Cancer 2023 被引用: 267

  17. Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600–Mutant Unresectable or Metastatic Melanoma

    著者: Reinhard Dummer, Georgina V. Long, Caroline Robert, Hussein A. Tawbi, Keith T. Flaherty, Paolo A. Ascierto, Paul Nathan, Piotr Rutkowski, О. В. Леонов, Caroline Dutriaux, Mario Mandalà, Paul Lorigan, Pier Francesco Ferrucci, Jean‐Jacques Grob, Nicolás Meyer, Helen Gogas, Daniil Stroyakovskiy, Ana Arance, Jan C. Brase, Steve Green, T Haas, Aisha Masood, Eduard Gasal, Antoni Ribas, Dirk Schadendorf - 2022 被引用: 146

  18. Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

    著者: G.V. Long, K.T. Flaherty, Daniil Stroyakovskiy, Helen Gogas, E. Levchenko, Filippo de Braud, J. Larkin, C. Garbe, T. Jouary, A. Hauschild, Vanna Chiarion‐Sileni, C. Lebbe, M. Mandalá, M. Millward, Ana Arance, Igor Bondarenko, J.B.A.G. Haanen, J. Hansson, Jochen Utikal, Virginia Ferraresi, P. Mohr, V. Probachai, Dirk Schadendorf, Paul Nathan, C. Robert, A. Ribas, M.A. Davies, S.R. Lane, J.J. Legos, B. Mookerjee, Jean‐Jacques Grob - Annals of Oncology 2017 被引用: 652

  19. Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma

    著者: Laura A. Bolte, Karla A. Lee, Johannes R. Björk, Emily R. Leeming, Marjo Campmans‐Kuijpers, Jacco J. de Haan, Arnau Vich Vila, Andrew Maltez Thomas, Nicola Segata, Ruth Board, Mark Harries, Paul Lorigan, Elisabeth G.E. de Vries, Paul Nathan, Rudolf S.N. Fehrmann, Véronique Bataille, Tim D. Spector, Geke A.P. Hospers, Rinse K. Weersma - JAMA Oncology 2023 被引用: 96

  20. ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee

    著者: Ulrich Keilholz, P.A. Ascierto, Reinhard Dummer, Caroline Robert, Paul Lorigan, Alexander C. J. van Akkooi, Ana Arance, Christian U. Blank, V. Chiarion Sileni, Marco Donia, Mark B. Faries, Caroline Gaudy‐Marqueste, Helen Gogas, Jean‐Jacques Grob, Matthias Gückenberger, John B.A.G. Haanen, Andrew Hayes, Christoph Höeller, Célèste Lebbé, Iwona Ługowska, Mario Mandalà, Iván Márquez‐Rodas, Paul Nathan, Bart Neyns, Roger Olofsson Bagge, Susana Puig, Piotr Rutkowski, Bastian Schilling, Vernon K. Sondak, Hussein A. Tawbi, Alessandro Testori, Olivier Michielin - Annals of Oncology 2020 被引用: 233

  21. The gut microbiome: what the oncologist ought to know

    著者: Karla A. Lee, Marilan Luong, Heather Shaw, Paul Nathan, Véronique Bataille, Timothy D. Spector - British Journal of Cancer 2021 被引用: 147

  22. Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)

    著者: Richard D. Carvajal, Sophie Piperno‐Neumann, Ellen Kapiteijn, Paul B. Chapman, Stephen Jay Frank, Anthony M. Joshua, Josep M. Piulats, Pascal Wolter, Véronique Cocquyt, Bartosz Chmielowski, T.R. Jeffry Evans, Lauris Gastaud, Gerald P. Linette, Carola Berking, Jacob Schachter, Manuel Rodrigues, Alexander N. Shoushtari, Delyth Clemett, Dana Ghiorghiu, G Mariani, Shirley Spratt, Susan Lovick, Peter Barker, Elaine Kilgour, Zhongwu Lai, Gary K. Schwartz, Paul Nathan - Journal of Clinical Oncology 2018 被引用: 275

  23. Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

    著者: Antoni Ribas, Richard Kefford, Margaret Marshall, Cornelis J.A. Punt, John B.A.G. Haanen, Maribel Mármol, Claus Garbe, Helen Gogas, Jacob Schachter, Gerald P. Linette, Paul Lorigan, Kari Kendra, Michele Maio, Uwe Trefzer, Michael Smylie, Grant A. McArthur, Brigitte Dréno, Paul Nathan, Jacek Mackiewicz, John M. Kirkwood, Jesús Gómez-Navarro, Bo Huang, Dmitri Pavlov, Axel Hauschild - Journal of Clinical Oncology 2013 被引用: 815

  24. Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study

    著者: Mahrukh M. Syeda, Jennifer Wiggins, Broderick C. Corless, Georgina V. Long, Keith T. Flaherty, Dirk Schadendorf, Paul Nathan, Caroline Robert, Antoni Ribas, Michael A. Davies, Jean‐Jacques Grob, Eduard Gasal, Matthew Squires, Mahtab Marker, James E. Garrett, Jan C. Brase, David Polsky - The Lancet Oncology 2021 被引用: 93